Theradiag SA

Research Theradiag SA (ALTHE) on Bullrun: market cap EUR 48.32M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALTHE
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 48.32M
• Financial periodFY2024
• RevenueEUR 830.21K
• Revenue growth-54.4%
• Net income-EUR 5.76M
• Free cash flow-EUR 3.01M
• Gross margin-346.0%

Valuation Snapshot

latest market cap is EUR 48.32M.

About Theradiag SA

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

Frequently asked questions

What is Theradiag SA's market cap?

Theradiag SA's market capitalization is EUR 48.32M.

What does Theradiag SA do?

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins;